Derudover havde 15 af 214 patienter i alendronat- gruppen (7, 0%) oplevet en non- vertebral fraktur sammenlignet med 16 af 214 patienter i FORSTEO- gruppen (7, 5%) (p=0, 84).
In addition, 15 of 214 patients in the alendronate group (7.0%) had experienced a nonvertebral fracture compared with 16 of 214 patients in the FORSTEO group (7.5%) (p=0.84).